Prevalence of conditions associated with human immunodeficiency and hepatits virus infections among persons with haemophilia, 2001-2003

Haemophilia

Volumn 11, Issue 5, 2005, Pages 516-528

  Goedert, James J ^a   Siegel, Jaime ^b   Miller, Kay ^b   Lederman, Michael M ^c   Thompson, Alexis ^d   Browning, Brittan ^d   Gamerman, Susan ^d   McRedmond, Kevin ^e   Withycombe, Janice ^e   Gruppo, Ralph ^f   Stack, Gina ^f   Lusher, Jeanne ^g   Percy, Linda ^g   Nugent, Diane ^h   McDaniel, Marianne ^h   Manno, Catherine ⁱ   Butler, Regina ⁱ   Wade, Amanda ⁱ   Angiolillo, Anne ^j   Luban, Naomi L C ^j   Guelcher, Christine ^j   Tarantino, Michael ^k   Greer, Suzi ^k   Gill, Joan ^l   Nelson, Jodie ^l   White, Gilbert ^m   Fried, Michael ^m   Grimsley, Aime L ^m   DiMichele, Donna ⁿ   Goldberg, Ilene ⁿ   French, James ^o   Hibner, Sandra ^o   Steinberg, James ^p   Faust, Steven ^p   Key, Nigel ^q   Hannemann, Vicky ^q   Kessler, Craig M ^r   Lee, Anastasia E ^r   Eyster, M Elaine ^s   Galli, Kathryn ^s   Jenkins, Gillian ^s   Bernstein, Zale P ^t   Belling, Linda ^t   Shapiro, Amy ^u   Halley, Marge ^u   Noblet, Patti ^u   Jardine, Lawrence ^v   Laudenbach, Lori ^v   Lipton, Richard ^w   Pece, Christine ^w   Leissinger, Cindy A ^x   Schmidt, Cecilia ^x   Carr, Marcus ^y   Nolte, Melinda ^y   Manco Johnson, Marilyn ^z   Giambartolomei, Sheryl ^z   Rubin, Sheldon H ^aa   Belliveau, Dorine ^aa   Aledort, Louis ^ab   McCarthy, Johanna ^ab   Lemons, Richard ^ac   Bleak, Shirley ^ac   Kraut, Eric ^ad   Witkoff, Leslie ^ad   Sexauer, Charles ^ae   Kiplinger, Felicia ^ae   Thompson, Arthur ^af   Cooper, Charles ^af   Britton, Howard ^ag   Cobb, Kathi ^ag   Reimers, Hans Joachim ^ah   Bagato, Judy A ^ah   Powell, Jerry S ^ai   Herr, Muriel ^ai   Scott, Karen ^ai   Hutter, John ^aj   Damiano, Mary Lou ^aj   Navarro, Willis ^ak   Roth, Jessie ^ak   Palascak, Joseph ^al   Sherman, Kenneth ^al   Heffner, Madeline ^al   DiPaolo, Jorge ^am   Lammer, Michael ^am   Iyer, Rathi ^an   Matthew, Prasad ^ao   Schwartz, Marcia ^ao   Konkle, Barbara ^ap   Vijayanathan, Nirmala ^ap   Dugdale, Marion ^aq   Lilley, Donald ^aq   Hoots, Keith ^ar   Brown, Deborah ^ar   Ullman, Megan ^ar   Neff, Anne ^as   Klintworth, Steven ^as   Sabio, Hernan ^at   Smith, Anita ^at   Karafoulidou, Anastasia ^au   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

^e Palmetto Richland Memorial Hospital   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^h CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^k Comprehensive Bleeding Disorders Centre ^*  (United States)

^l Comprehensive Centre for Bleeding Disorders ^*  (United States)

^m UNIVERSITY OF NORTH CAROLINA   (United States)

ⁿ WEILL CORNELL MEDICAL CENTER   (United States)

^o Child Adol and Family Psychiatry   (United States)

^p EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q Fairview University   (United States)

^r GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^s PENN STATE COLLEGE OF MEDICINE   (United States)

^t Haemophilia Center of Western New York Inc   (United States)

^u INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

^v LONDON HEALTH SCIENCES CENTRE   (Canada)

^w LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^x TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^z Mountain States Regional Hemophilia and Thrombosis Center   (United States)

^aa Moncton Haemophilia Clinic   (Canada)

^ab MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^ac PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^ad OHIO STATE UNIVERSITY   (United States)

^ae Children's Hospital Oklahoma City   (United States)

^af PUGET SOUND BLOOD CENTER   (United States)

^ag Santa Rosa Children's Hospital   (United States)

^ah SAINT LOUIS UNIVERSITY CANCER CENTER   (United States)

^ai UNIVERSITY OF CALIFORNIA   (United States)

^aj UNIVERSITY OF ARIZONA   (United States)

^ak UNIVERSITY OF CALIFORNIA   (United States)

^al UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^am UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^an UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^ao UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^ap PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^aq UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^ar UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^as VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^at WAKE FOREST SCHOOL OF MEDICINE   (United States)

^au UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

more..

Author keywords

Acquired immunodeficiency syndrome; Alcoholism; Cancer; Cohort study; Haemophilia; Hepatitis B; Hepatitis C

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B VACCINE; INTERFERON; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PEGINTERFERON; RIBAVIRIN; SERUM ALBUMIN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ANEMIA; ARTICLE; ASCITES; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMOPHILIA; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; JAUNDICE; LIVER CELL CARCINOMA; LIVER DISEASE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NONHODGKIN LYMPHOMA; PANCYTOPENIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SELF REPORT; SPLENOMEGALY; THROMBOCYTE COUNT; VIRUS CARRIER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATOMEGALY; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PANCYTOPENIA; VON WILLEBRAND DISEASE;

EID: 24644456388     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2005.01138.x     Document Type: Article

References (24)

1. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quart S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused haemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1993; 6: 602-10.
2. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 1990; 76: 254-6.
3. Troisi CL, Hollinger FB, Hoots WK et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood 1993; 81: 412-8.
4. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36(Suppl. 1): S35-6.
5. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003; 362: 2095-100.
6. Goedert JJ, Eyster ME, Lederman MM et al. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002; 100: 1584-9.
7. Ehmann WC, Eyster ME, Wilson SE, Andes WA, Goedert JJ. Relationship of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected with HIV. Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1994; 7: 1095-8.
8. UK Haemophilia Centre Doctors' Organisation. The impact of HIV on mortality rates in the complete UK haemophilia population. AIDS 2004; 18: 525-33.
9. Ehmann WC, Eyster ME, Aledort LM, Goedert JJ. Causes of death in haemophilia. Nature 1995; 378: 124.
10. Darby SC, Ewart DW, Giangrande PL et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet 1997; 350: 1425-31.
11. Suryanarayana K, Wiltrout TA, Vasquez GM, Hirsch VM, Lifson JD. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses 1998; 14: 183-9.
12. Zucker SD, Qin X, Rouster SD et al. Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci USA 2001; 98: 12671-6.
13. Murphy RL, Sanne I, Cahn P et al. Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results. AIDS 2003; 17: 2603-14.
14. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341: 22-6.
15. Jardi R, Rodriguez F, Buti M et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001; 34: 404-10.
16. Monto A, Patel K, Bostrom A et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004; 39: 826-34.
17. Wiley TE, McCarthy M, Breidi L, Layden TJ. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998; 28: 805-9.
18. Goedert JJ, Kessler CM, Aledort LM et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989; 321: 1141-8.
19. Kroner BL, Rosenberg PS, Aledort LM, Alvord WG, Goedert JJ. HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1994; 7: 279-86.
20. O'Brien TR, Blattner WA, Waters D et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996; 276: 105-10.
21. Opravil M, Ledergerber B, Furrer H et al. Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count >350 × 10(6)/l. AIDS 2002; 16: 1371-81.
22. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.
23. DiMichele DM, Mirani G, Wilfredo CP, Trost DW, Talal AH. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia 2003; 9: 613-8.
24. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-75.